The role of modeling and economics
Thursday, June 16, 2016
Scientific Session
•
SS 03
•
2:15 PM
>
3:45 PM
•
The role of modeling and economics
•
Mozart 1-3
Scientific Session
•
SS 03-04
•
What can models tell us about reduced dose schedules?
>
M.
Marc
Brisson
•
SS 03-05
•
What do we need to know about cancer control in low and middle income settings?
See abstract
>
S.
Silvia
Franceschi
•
SS 03-07
•
What do we need to know about screening in the post-nonavalent vaccine era?
>
J.
Joakim
Dillner
•
SS 03-08
•
What can models tell us about screening in the post-nonavalent vaccine era?
See abstract
>
K.
Karen
Canfell
•
SS 03-01
•
What do we need to know about HPV disease to inform reliable models of vaccination and screening?
See abstract
>
H.
Hans
Berkhof
•
SS 03-02
•
What do epidemiological studies tell us about HPV disease?
See abstract
>
E.
Eduardo
Franco
•
SS 03-06
•
WHAT DO WE NEED TO KNOW ABOUT CANCER CONTROL IN LOW AND MIDDLE INCOME SETTINGS? A MODELLER’S RESPONSE
See abstract
>
M.
Mark
Jit
•
SS 03-03
•
WHAT DO WE KNOW AND WHAT DO WE NEED TO KNOW ABOUT REDUCED-DOSE SCHEDULES?
See abstract
>
A.
Aimée
Kreimer
|